Sarcopenia and metabolic dysfunction-associated steatotic liver disease: The role of exercise-related biomarkers

doi:10.4254/wjh.v17.i2.101165

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-1)

Sum=0

Feb 27, 2025 (publication date) through Feb 20, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Hepatol. Feb 27, 2025; 17(2): 101165
Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.101165

Open in New Tab Full Size Figure Download Figure

Figure 1 Bidirectional relationship between sarcopenia and metabolic dysfunction-associated steatotic liver disease in reference to circulating irisin level.

Citation: Al-Nimer MS. Sarcopenia and metabolic dysfunction-associated steatotic liver disease: The role of exercise-related biomarkers. World J Hepatol 2025; 17(2): 101165
URL: https://www.wjgnet.com/1948-5182/full/v17/i2/101165.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i2.101165